<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03898570</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-47517</org_study_id>
    <nct_id>NCT03898570</nct_id>
  </id_info>
  <brief_title>Distributed Registry</brief_title>
  <official_title>Distributed Registry Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test if a patient can be directly connected to a quality
      assurance (QA) database, traditionally known as a registry. Patient-reported outcomes (PRO)
      data will be entered into the database directly from a patient's mobile phone from their
      index procedure for 12 months. The investigators hope this study to be a &quot;proof of concept&quot;
      for such a distributed registry and evaluate 1) consistency of data acquisition, 2)
      engagement of patients, 3) overall value of patient-reported outcomes to enhance long term
      follow up.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Patient Reported Outcomes (PROs) using mobile app</measure>
    <time_frame>1 Year</time_frame>
    <description>PROs are any report of the status of a patient's health condition that comes directly from the patient, without interpretation of the patient's response by a clinician or anyone else</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Intermittent Claudication</condition>
  <condition>Arteriosclerosis</condition>
  <condition>Atherosclerosis</condition>
  <condition>Arterial Occlusive Diseases</condition>
  <condition>Vascular Diseases</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Peripheral Vascular Diseases</condition>
  <condition>Signs and Symptoms</condition>
  <condition>Patient Compliance</condition>
  <arm_group>
    <arm_group_label>Patients undergoing vascular surgery procedures</arm_group_label>
    <description>Patients will report outcomes via their smartphone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Patient reported outcomes</intervention_name>
    <description>Patients will download the research app onto their phone and enter pertinent medical history and surgical history data similar to standard registries for specific procedures. Over the next 12 months the investigators will obtain patient-reported outcomes (PROs) using the patient's phone.
Specifically, the investigators will obtain daily activity data, weekly 6-minute-walk tests, and quarterly quality of life surveys</description>
    <arm_group_label>Patients undergoing vascular surgery procedures</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All adults with an iPhone 5s or higher who can read English
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with cardiovascular disease who are scheduled or have undergone either a)
             open or endovascular vascular procedure, or b) open or percutaneous cardiac procedure.

          2. Patients with smartphones (iOS or Android) with unlimited data plans.

          3. Patients who agree to remote surveillance

        Exclusion Criteria:

          1. Patients unwilling to download a research study app.

          2. Data plans which are not unlimited.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oliver O Aalami, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Doran S Triggs, BS</last_name>
    <phone>6508523459</phone>
    <phone_ext>63459</phone_ext>
    <email>dorant@stanford.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Helle N Nielsen, MPH</last_name>
    <phone>6505972031</phone>
    <email>hnnb@stanford.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Palo Alto Veterans Hospital</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doran S Triggs, BS</last_name>
      <phone>650-852-3459</phone>
      <email>dorant@stanford.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94588</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doran S Triggs, BS</last_name>
      <phone>650-852-3459</phone>
      <email>dorant@stanford.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>March 29, 2019</study_first_submitted>
  <study_first_submitted_qc>March 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2019</study_first_posted>
  <last_update_submitted>May 2, 2019</last_update_submitted>
  <last_update_submitted_qc>May 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Oliver O. Aalami</investigator_full_name>
    <investigator_title>CLINICAL ASSOCIATE PROFESSOR, SURGERY - VASCULAR SURGERY</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Intermittent Claudication</mesh_term>
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Signs and Symptoms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

